Lyme Disease
📧 Sign up to get email alerts when something new happens for Lyme Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age [Phase 1, Phase 2]
Phase 1/2 study evaluating safety and immunogenicity of mRNA-1975 and mRNA-1982 for Lyme disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) [Phase 3]
Phase 3 trial assessing efficacy, safety, tolerability, immunogenicity, and lot-consistency of a 6-valent OspA-based Lyme disease vaccine (V…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Searching for Persistence of Infection in Lyme Disease [EARLY_Phase 1]
This clinical trial update indicates that an early-phase 1 study sponsored by the National Institute of Allergy and Infectious Diseases on t…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Symptomatic Management of Lyme Arthritis [Phase 3]
Phase 3 trial investigating symptomatic management of Lyme arthritis has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children [Phase 3]
Pfizer conducted a Phase 3 safety study of a Lyme disease vaccine in healthy children; the trial has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age [Phase 1, Phase 2]
A completed Phase 1/2 study by Moderna evaluated the safety and immunogenicity of two Lyme disease vaccine candidates, mRNA-1975 and mRNA-19…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Effects of Psilocybin in Post-Treatment Lyme Disease [Phase 1]
A Phase 1 study at Johns Hopkins evaluating psilocybin for post-treatment Lyme disease syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy [NA]
This update outlines the safety and effectiveness assessment of the BlinkER System for facial nerve palsy conditions, including Bell's palsy…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Borrelia B-cell Diagnostics
Clinical trial update indicates a study on Borrelia B-cell diagnostics is currently recruiting at University Children’s Hospital, Zurich.
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: BOrrelia BUrgdorferi IN Children and Adolescents
A completed clinical trial update on Borrelia burgdorferi infection (Lyme disease) in children and adolescents, sponsored by University Chil…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Xenodiagnosis After Antibiotic Treatment for Lyme Disease [NA]
This clinical trial update notes that a study of xenodiagnosis after antibiotic treatment for Lyme disease has completed and posted results …
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Feasibility of Teleyoga for Treatment of Lyme Disease [NA]
Feasibility study of teleyoga for Lyme disease has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease [Phase 1, Phase 2]
This clinical-trial update reports Phase 1/2 results for disulfiram aimed at reducing fatigue and improving quality of life in patients with…
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel [NA]
Clinical trial update on detecting Borrelia bacteria in early Lyme borreliosis using the T2Lyme panel; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study. [Phase 2]
Phase 2 randomized, observer-blind study evaluating immunogenicity and safety of a Lyme borreliosis vaccine in healthy adults (18-65). Resul…
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Phase 1/2 Lyme Vaccine Study [Phase 1, Phase 2]
Phase 1/2 clinical trial update for a Lyme borreliosis prophylaxis vaccine completed.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: A School-Based Intervention to Reduce Lyme Disease [NA]
Sponsored by Brigham and Women's Hospital, this completed school-based trial aimed at reducing Lyme disease has posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes [Phase 3]
Phase 3 clinical trial on passive prophylaxis of Lyme disease using permethrin-treated clothing was terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Comparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans [NA]
A completed clinical trial compared doxycycline with cefuroxime axetil for the treatment of erythema migrans in Lyme disease.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Sofia 2 Lyme FIA Whole Blood Clinical Study
Clinical trial update for Quidel's Sofia 2 Lyme FIA Whole Blood test shows the study (NCT03238274) is completed.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Persistent Lyme Empiric Antibiotic Study Europe [Phase 4]
A Phase 4 clinical trial evaluating empiric antibiotic treatment for persistent Lyme disease has completed in Europe.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Doxycycline in Therapy of Erythema Migrans
A clinical trial evaluating doxycycline for erythema migrans (Lyme disease) has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: Culture Media for Borrelia Burgdorferi Sensu Lato [NA]
The study reports results posted in 2015 for culture media used to grow Borrelia burgdorferi sensu lato in patients with erythema migrans (L…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice [Phase 4]
Phase 4 trial comparing three antibiotic regimens for erythema migrans has completed in general practice. The study was sponsored by Morten …
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Lyme Disease Prevention Program [Phase 3]
A Phase 3 trial evaluating a Lyme disease prevention program has completed, sponsored by Brigham and Women's Hospital.